A61M2205/35

INSULIN PUMP HAVING BASAL RATE TESTING FEATURES
20220101978 · 2022-03-31 ·

Methods of establishing an insulin delivery rate in a pump and an insulin pump are disclosed. A method includes selecting a set of alerts from one or more sets of alerts. The method also includes initiating a test process based on the set of alerts. The method further includes, upon activation of each alert in the selected set of alerts, prompting a user to input a blood glucose level.

MEDICATION DELIVERY DEVICE WITH MECHANICAL LOCKING SYSTEM
20220096751 · 2022-03-31 ·

A medication delivery device having a lock element. The device is connectable to an electrical plug of a conduit. The device includes an external housing with an opening that ports to a plug receiving hollow within an interior volume. An electrical circuit connected to at least one of a rechargeable battery and a memory controller includes a connection element within the plug receiving hollow. The lock element travels within the plug receiving hollow when a dose delivery assembly of the device operates for forcing medication from the device. The lock element is sized and positioned to have its travel halted by abutment with the plug, when the plug is within the plug receiving hollow and electrically interfacing with the connection element, to thereby halt the dose delivery assembly from further operating for forcing medication from the device.

OPTIMIZED INTRATHECAL DRUG DELIVERY
20220111188 · 2022-04-14 ·

An intrathecal drug delivery system configured to monitor one or more physiological conditions of the patient to look for opportunities to time medicament delivery to coincide with patient activity inferring heightened cerebrospinal fluid oscillations, thereby improving dispersion of the medicament within the intrathecal space of the patient. The intrathecal drug delivery system includes an implantable medical pump, one or more physiological sensors, and an external programmer configured to program the implantable medical pump with a treatment protocol specifying at least one period of time during which a specified quantity of medicament is to be administered during which the implantable medical pump utilizes data from the one or more physiological sensors to time delivery of the medicament.

Methods and apparatus for improved medication delivery devices

Embodiments provide systems, methods, and apparatus for a medication delivery device. The device includes a dose selector for selecting an amount of medication to deliver; a first capacitive sensor adjacent the dose selector and operative to detect linear displacement of the dose selector during medication delivery; a screw coupled to the dose selector; a second capacitive sensor adjacent the screw and operative to detect linear displacement of the screw during medication delivery; and a processor coupled to the first and second capacitive sensors and operative to determine an amount of medication actually delivered by the medication delivery device. Numerous other aspects are provided.

SYSTEMS, APPARATUSES AND METHODS FOR ENHANCED NOTIFICATIONS TO USERS OF WEARABLE MEDICAL DEVICES

A wearable medical device (e.g., wearable drug delivery pump) sends a request to another device for generation of an audible or vibratory notification at the other device, which is helpful when the wearable medical device is obscured by a user's clothing or the user is vision or hearing impaired. The other device receiving the request to generate a notification can be a remote controller or smartphone paired with the wearable medical device, or a smart watch or a Bluetooth (BT)-enabled headset or other device paired with the remote controller. The wearable medical device is configured with a BT stack that allows the device to pair with its controller in a secure bonded relationship, but to send signals requiring less security (e.g., requests for generation of notifications) to other devices (e.g., a BT-enabled headset or smart watch) using a more ubiquitous wireless protocol such as a standard BT protocol with broadcast mode.

SYSTEM AND METHOD FOR COLLECTION OF FIT DATA RELATED TO A SELECTED MASK

A system and method to collect feedback data from a patient wearing an interface such as a mask when using a respiratory pressure therapy device such as a CPAP device. The system includes a storage device including a facial image of the patient. An interface in communication with the respiratory pressure therapy device collect operational data from when the patient uses the interface. A patient interface collects subjective patient input data from the patient in relation to the patient interface. An analysis module correlates a characteristic of the interface with the facial image data, operational data and subjective patient input data.

Charging device for a physiological signal transmitter and a charging method for the same
11315671 · 2022-04-26 · ·

A charging device for a physiological signal transmitter used to receive a physiological signal from the subcutaneous tissue of a living body and having a first electrical connecting port is disclosed. The charging device includes a transmitter placing seat and a charging module. The transmitter placing seat includes a bearing surface for placing the physiological signal transmitter and an opening configured to align with the first electrical connection port of the physiological signal transmitter. The charging module includes a second electrical connecting port, a third electrical connecting port, a circuit assembly and a control module. The second electrical connecting port is disposed in the opening, and driven to move between a first position and a second position. The third electrical connecting port connects to a power source.

Drug delivery device, method of manufacture, and method of use

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.

ACUTE KIDNEY INJURY MONITORING

An example device includes memory configured to store an observer and processing circuitry communicatively coupled to the memory. The processing circuitry is configured to receive, from an oxygen sensor, an oxygen sensor signal indicative of an amount of dissolved oxygen in a fluid, wherein the oxygen sensor is located in a distal portion of a catheter or distal to a distal end of the catheter, and wherein the fluid flows to the oxygen sensor from a location within a patient. The processing circuitry is configured to determine, based on the oxygen sensor signal, a measurement of the amount of dissolved oxygen in the fluid. The processing circuitry is configured to apply the observer to the measurement of the amount of dissolved oxygen in the fluid. The processing circuitry is configured to determine, based on the observer, an estimate of an amount of dissolved oxygen in the fluid at the location.

Dialysis machine tubing protection

Tubing protectors, systems including tubing protection, and methods for protecting tubing, are disclosed, such as for protecting tubing connected between a patient and a dialysis machine (e.g., peritoneal dialysis machine) during a dialysis treatment. A tubing protector may include a tubing sheath attachable to a patient. The sheath may include a first portion for receiving and protecting a length of tubing extendible in the sheath, such as to minimize collapse, kinking, blockage, or combinations thereof, along the length of the tubing. A second portion may comprise a flexible material and enclose the first portion. The first portion may comprise a resilient material, which allows for movement in the sheath and has a strength to allow for reorientation of the tubing, while withstanding deformation of the tubing along the length. The first portion may be a coil, a plurality of rings, a woven mesh, or a solid tube, or combinations thereof.